Literature DB >> 8548692

Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.

P J Willson1, A Rossi-Campos, A A Potter.   

Abstract

These studies were done to develop a subunit vaccine for swine that would protect against disease, but not create unacceptable tissue reactions at the immunization site. Swine were used to evaluate the local effects of subunit vaccines prepared from extracts of Actinobacillus pleuropneumoniae serotype 1 containing one of a wide variety of adjuvants. The antigen was an anionic fraction of a saline extract of A. pleuropneumoniae (ANEX). The adjuvants used were vegetable oils (peanut, sesame, canola, or corn oils, vitamin E, or Lipposyn II emulsion); mineral oil (Marcol-52) and other materials (aluminum hydroxide, polyethylene glycol, Quil-A, Amphigen, or Emulsigen-Plus). Two types of experiments were done. In the 1st set of experiments, pigs were given multiple simultaneous injections in different sites and euthanized on days 1, 3, 7, 14, 21, or 28. Tissues were examined for gross and histopathological lesions. In the 2nd set of experiments, 48 pigs were allocated to 6 groups and vaccinated twice with a vaccine containing ANEX antigen combined with one of various adjuvants. Antibody responses and protection from challenge were evaluated. Among the adjuvants that were tested, mineral oils induced protective immunity, although the mineral oil Marcol-52 resulted in severe tissue reactions. The vegetable oils induced little protective immunity, and some of them were quite irritating. The response to the other materials ranged from little irritation or protection induced by the vaccine containing aluminum hydroxide to effective protection without irritation after vaccination with ANEX/Amphigen or ANEX/Emulsigen-Plus combinations. In conclusion, swine were protected against disease by a subunit vaccine that did not create unacceptable tissue reaction at the immunization site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548692      PMCID: PMC1263785     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine.

Authors:  B E Straw; N J MacLachlan; W T Corbett; P B Carter; H M Schey
Journal:  Can J Comp Med       Date:  1985-04

2.  Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1.

Authors:  D L Stine; P J Fedorka-Cray; M J Huether; M J Gentry; G A Anderson
Journal:  Am J Vet Res       Date:  1994-09       Impact factor: 1.156

3.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Isolation of Haemophilus somnus antigens and their use as vaccines for prevention of bovine thromboembolic meningoencephalitis.

Authors:  L R Stephens; P B Little; B N Wilkie; D A Barnum
Journal:  Am J Vet Res       Date:  1984-02       Impact factor: 1.156

Review 5.  Adjuvants--a balance between toxicity and adjuvanticity.

Authors:  R K Gupta; E H Relyveld; E B Lindblad; B Bizzini; S Ben-Efraim; C K Gupta
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

6.  Protective efficacy of capsule extracts of Haemophilus pleuropneumoniae in pigs and mice.

Authors:  S Rosendal; O P Miniats; P Sinclair
Journal:  Vet Microbiol       Date:  1986-09       Impact factor: 3.293

7.  Antibody production and tissue irritation in swine vaccinated with Actinobacillus bacterins containing various adjuvants.

Authors:  B E Straw; S Shin; D Callihan; M Petersen
Journal:  J Am Vet Med Assoc       Date:  1990-02-15       Impact factor: 1.936

8.  Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.

Authors:  G F Gerlach; C Anderson; S Klashinsky; A Rossi-Campos; A A Potter; P J Willson
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Vaccination against pleuropneumonia of pigs caused by Haemophilus pleuropneumoniae.

Authors:  S Rosendal; D S Carpenter; W R Mitchell; M R Wilson
Journal:  Can Vet J       Date:  1981-02       Impact factor: 1.008

10.  Optimization of hydrophile-lipophile balance for improved efficacy of Newcastle disease and avian influenza oil-emulsion vaccines.

Authors:  H D Stone
Journal:  Avian Dis       Date:  1988 Jan-Mar       Impact factor: 1.577

View more
  8 in total

1.  A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

2.  Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.

Authors:  Yuanyi Li; Gabriela Martinez; Marcelo Gottschalk; Sonia Lacouture; Philip Willson; J Daniel Dubreuil; Mario Jacques; Josee Harel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Pathogenesis of porcine Actinobacillus pleuropneumonia: Part I. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; W D Yates
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

4.  Cloning and characterization of the gene coding for NADPH-sulfite reductase hemoprotein from Actinobacillus pleuropneumoniae and use of the protein product as a vaccine.

Authors:  P J Willson; G F Gerlach; S Klashinsky; A A Potter
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

Review 5.  Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Authors:  Bassel Akache; Felicity C Stark; Gerard Agbayani; Tyler M Renner; Michael J McCluskie
Journal:  Methods Mol Biol       Date:  2022

6.  The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.

Authors:  X P Ioannou; P Griebel; R Hecker; L A Babiuk; S van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: roles of proinflammatory cytokines.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; D M Haines; W D Yates
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

8.  Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.

Authors:  Léa Martelet; Sonia Lacouture; Guillaume Goyette-Desjardins; Guy Beauchamp; Charles Surprenant; Marcelo Gottschalk; Mariela Segura
Journal:  Pathogens       Date:  2017-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.